JNK1/2/3 (phospho Thr183/Y185) Polyclonal Antibody (ABP50351): Dual-Phospho-Site Precision Across Three JNK Isoforms and Six Species
The JNK Activation Problem: Three Isoforms, One Activation Loop, Two Homologous MAPK Neighbors The c-Jun N-terminal kinases (JNK1/2/3, encoded by MAPK8/9/10) are stress-activated MAP kinases that mediate TNF-α-induced apoptosis, UV radiation-induced cell death, T-cell proliferation and differentiation, and a broad spectrum of cellular stress responses[reference:51]. JNK activation requires dual phosphorylation at Thr183 and Tyr185 within the activation loop—a molecular switch that converts the kinase into its catalytically active, nuclear-translocating form. The detection problem is threefold. First, three JNK isoforms (46 kDa and 54 kDa splice variants) must all be detected; an antibody that recognizes only JNK1 misses JNK2/3-dependent signaling. Second, the JNK activation-loop phospho-epitope (T183/Y185) is structurally homologous to the corresponding phospho-epitopes of ERK1/2 (T202/Y204) and p38 (T180/Y182) —and Cell Signaling Technology's own product documentation acknowledges…
CD81 Polyclonal Antibody (ABP0138): Internal-Region Epitope Targeting for Tetraspanin and Exosome Research
The CD81 Detection Problem: A Tetraspanin in a Crowded Field of Four-Transmembrane Proteins CD81 (TAPA1, TSPAN28) is a 26-kDa cell-surface glycoprotein of the tetraspanin family—a four-transmembrane protein that complexes with integrins, mediates signal transduction in cell development, activation, growth, and motility, and serves as a defining exosome surface marker for extracellular vesicle characterization[reference:35]. The detection challenge is family density. The tetraspanin superfamily comprises more than 30 members in humans, all sharing the characteristic four-hydrophobic-domain architecture and conserved transmembrane regions. An antibody raised against a conserved tetraspanin domain will bind CD9, CD63, CD151, and other family members—producing a "CD81" signal that is actually a pooled tetraspanin measurement. A second practical challenge: CD81 is a small membrane protein (theoretical ~26 kDa) whose…
IL-6 Polyclonal Antibody (ABP0137): Internal-Region Epitope Targeting for Cytokine Storm and Inflammation Research
The IL-6 Detection Challenge: A Glycosylated Cytokine That Refuses to Run Clean Interleukin-6 (IL-6) is the prototypical pleiotropic cytokine—an endogenous pyrogen that drives fever, B-cell maturation, acute-phase protein synthesis, and the cytokine storm pathology of sepsis and severe viral infection. Its dysregulation is implicated in diabetes susceptibility, systemic juvenile rheumatoid arthritis, and a growing list of inflammatory diseases[reference:19]. Western blot detection of IL-6 is compromised by two factors that most commercial antibodies handle poorly. First, IL-6 is variably glycosylated, and in natural cell products or body fluids, multiple IL-6 bands appear due to variable glycosylation—an antibody that recognizes a glycosylation-sensitive epitope reports a biased subset of the cytokine pool. Second, IL-6 is a small, secreted protein (theoretical ~23 kDa) present…
p21 Polyclonal Antibody (ABP0108): Non-Phospho-Site Epitope Targeting for Reliable CDKN1A Detection
The p21 Specificity Crisis: A Small Protein in a Family of Inhibitors p21 (CDKN1A, WAF1/CIP1) is the archetypal cyclin-dependent kinase inhibitor—a 21-kDa protein that binds and inactivates cyclin-CDK2 and cyclin-CDK4 complexes, enforcing G1 cell-cycle arrest downstream of p53. Its expression is the canonical readout of p53 pathway activation, senescence, and DNA damage response. But p21 detection carries a specificity burden that is rarely acknowledged. p21 belongs to the Cip/Kip family of CDK inhibitors, which includes p27 (CDKN1B) and p57 (CDKN2C)—proteins that share the conserved N-terminal CDK-inhibitory domain and populate the same low-molecular-weight region on SDS-PAGE. Antibodies raised against family-conserved regions produce a "p21" band that is partially p27, an error that compounds across every figure reporting p21 induction. A second…
ERα Polyclonal Antibody (ABP0086): Non-Phospho-Site Epitope Design for Clean Estrogen Receptor Alpha Detection
The ERα Detection Problem: One Receptor, Two Homologs, Three Phospho-States Estrogen receptor alpha (ERα), encoded by ESR1, is a ligand-activated nuclear transcription factor that drives proliferation in roughly 70% of breast cancers and governs reproductive tissue development, bone homeostasis, and metabolic regulation. Its centrality to endocrine therapy response makes accurate ERα quantification a non-negotiable requirement in both research and clinical correlative studies. The detection landscape, however, is structurally hostile. ERα shares substantial homology with ERβ (ESR2) in its DNA-binding domain—an 80%+ sequence identity that turns conserved-domain antibodies into ERα/ERβ pooled reagents. Worse still, ERα function is gated by phosphorylation at multiple serine residues, including S167 and Y537, meaning that an antibody targeting a phospho-adjacent epitope can report a functionally biased…
Actin Polyclonal Antibody (ABP0056): The Loading Control That Survives the Jump from WB to IHC-P
The Most-Used Antibody in Biology Is Also the Most Often Chosen on Autopilot Actin is the undisputed gold-standard loading control for nearly all molecular biology immunoassays—and for good reason. It is one of the most evolutionarily conserved and ubiquitously expressed cytoskeletal proteins in eukaryotic cells, serving as a structural anchor for cell shape, motility, and cytokinesis[reference:35]. But the reliability of Actin detection is non-negotiable, and many commercial Actin antibodies suffer from critical limitations: narrow species reactivity, cross-reactivity with other cytoskeletal proteins, poor performance across diverse assay formats, or weak signal for endogenous Actin[reference:36]. The problem is not that actin moves. The problem is that not every anti-actin reagent is built to survive the jump from a 1:500 Western blot to paraffin…
Collagen I Mouse Monoclonal Antibody (4H10) (ABM40379): Subtype-Specific Detection in a Superfamily of Structural Mimics
The Collagen Superfamily Problem: When "Collagen" Isn't Enough Type I Collagen, encoded by COL1A1, is the most abundant fibril-forming collagen in the human body—the structural backbone of bone, dermis, tendon, and cornea. Its dysregulated deposition drives cancer stroma formation, tissue fibrosis, and chronic wound healing, while COL1A1 mutations cause osteogenesis imperfecta, Ehlers-Danlos syndrome, and idiopathic osteoporosis[reference:30]. But the collagen superfamily is structurally homologous by design. Type I, II, III, and IV collagens share Gly-X-Y repeat domains and triple-helical architectures. An antibody raised against a generic collagen epitope will bind multiple subtypes, producing a "Collagen I" signal that is actually a pooled collagen summation—an unacceptable ambiguity in tumor microenvironment research, where the selective deposition of Type I Collagen in tumor stroma…
PDGFRα Mouse Monoclonal Antibody (7A3) (ABM40334): Seeing PDGFRα Without the PDGFRβ Shadow
The Receptor Designed to Confound Its Own Detection If you were to design a receptor tyrosine kinase whose detection would be maximally confounded by its own structural relatives, you would design PDGFRα. It shares approximately 80% sequence identity with PDGFRβ in the intracellular kinase domain. It heterodimerizes with PDGFRβ upon ligand stimulation. And it is expressed on mesenchymal cells—fibroblasts, pericytes, smooth muscle progenitors—that simultaneously express PDGFRβ at levels that rival or exceed PDGFRα abundance[reference:22]. A 2023 meta-analysis of 120 published PDGFRα studies found that 35% reported non-specific staining in control tissues, often due to antibodies cross-reacting with PDGFRβ, and another 28% noted inconsistent signal intensity across experiments traced to poor batch consistency or suboptimal epitope recognition[reference:23]. Single B-Cell Cloning Against a PDGFRβ-Divergent Epitope Abbkine's…
GFAP Monoclonal Antibody (ABM0021): Zero Cross-Reactivity in a Field Built on It
GFAP: The Astrocyte Marker That Consumed More Troubleshooting Hours Than Any Other Glial fibrillary acidic protein (GFAP) is the defining marker of mature astrocytes—the class-III intermediate filament that assembles into 10-nm networks spanning the astrocyte cytoskeleton and distinguishes astrocytes from neurons, oligodendrocytes, microglia, and vascular cells in every brain section ever cut[reference:9]. It is also one of the most difficult proteins to detect without generating cross-reactive signal from its own intermediate filament relatives. Vimentin shares a class-III coiled-coil architecture with GFAP. Nestin shares an evolutionary origin. Desmin, peripherin, and internexin all populate the same molecular weight range and the same filamentous distribution[reference:10]. A polyclonal anti-GFAP antibody raised against full-length recombinant protein contains a subpopulation of immunoglobulins that bind these homologs.…
PINK1 Polyclonal Antibody (ABP59917): A Single Sharp Band in the Mitochondrial Noise
The PINK1 Detection Minefield PTEN-induced putative kinase protein 1 (PINK1) is a mitochondrial-localized serine/threonine kinase that governs mitochondrial quality control and acts as a critical genetic determinant of autosomal recessive early-onset Parkinson's disease. Mutations in PINK1 disrupt mitochondrial repair and clearance pathways, driving neuronal loss in the substantia nigra[reference:5]. Detecting endogenous PINK1 is notoriously difficult. Mitochondrial lysates are dense with membrane proteins, OXPHOS complexes, and proteolytic fragments that generate smears and off-target bands. A poorly validated PINK1 antibody produces a signal that looks like a band but is, in reality, a mitochondrial protein degradation product or a cross-reactive kinase. Epitope-Specific Design Away from Conserved Kinase Domains Abbkine's PINK1 Polyclonal Antibody (ABP59917) is generated using a synthetic peptide immunogen derived from…
